This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Copay, Reimbursement and Access Congress
October 12-14, 2022
Delivered as a Hybrid EventPhiladelphia, PA

Track B: Reimbursement Strategies and Contracting

Stay on the Pulse of Managed Market Trends to Ensure Product Access

Navigate the increased efforts to limit reimbursement of high-cost therapeutics, diving into formulary exclusions, high OOP costs, benefit design and more.

Expert Guidance to Accelerate Product Access Through Reimbursement Strategies and Contracting

Top Tips for Understanding the Utilization and Market Trends for Biosimilars

  • Analyze current payer and industry trends
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies

Multi-Stakeholder Discussions to Streamline Efficiencies

Benchmark best practices with leaders from across industry, including:

  • Bio/Pharma Manufacturers
  • Pharmacies
  • PBMs
  • Non-Profit/Academia

Explore Value-Based Contracting Frameworks and Considerations

  • Discuss various innovative contracting styles and their appropriate use, including value-based and outcomes-based contracting
  • Review the merits of selecting a traditional pathway for reimbursement and contracting
  • Assess challenges faced by manufacturers and payers